On Thursday, November 3, 2016, Memorial Sloan Kettering Cancer Center will host its eleventh annual Major Trends in Modern Cancer Research lecture for high school and college students. (Members of the public are also welcome to attend.) The event will take place from 5:30–7:30 PM on the first floor of Memorial Sloan Kettering’s Rockefeller Research Laboratories building (430 East 67th Street, between York and First Avenues).
Registration is easy, but finding a seat with a good view isn’t. This event has gotten so popular that the folks at MSKCC needed to set up satellite viewing stations in adjacent conference rooms. Get there a bit early if possible. Light refreshments have traditionally been served before the lectures begin (pizza, chips, fruit, soda, coffee). Single use MetroCards will be made available for any student who needs one to attend.
One point of extra credit will be awarded to all students who attend and complete this assignment for any one of the speakers. (Consult the Extra Credit webpage for more info.) Official attendance is taken by group photo at the end of the event. Submit your completed (typed) assignment to your supervising teacher at any time during the school day on Monday, November 7.
Memorial Sloan Kettering President Craig B. Thompson studies molecular signaling pathways that regulate nutrient uptake and the role these pathways play in the regulation of cell growth and survival.
|Hijacking the Genes: How Transcription Factors Promote Tumor Formation
Physician-scientist Yu Chen studies the role of transcription factors that are critical for prostate cancer development.
|Ion Channels in Calcium Signaling: Understanding the Atomic and Chemical Mechanisms
Structural biologist Stephen Long studies the mechanisms of ion channels and enzymatic membrane proteins using a combination of scientific approaches.
|Getting to Know Cancer: Using the Genome to Understand How Cancer Behaves
Molecular geneticist Elli Papaemmanuil studies patient data from clinical trials to explore how the genes in leukemia and other cancers affect disease progression and clinical outcomes.